Minoxidil

Use to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)

Minoxidil is indicated for the treatment of severe hypertension. It should not be used as the sole agent to initiate therapy. It is a peripheral vasodilator and should be given in conjunction with a diuretic, to control salt and water retention, and a beta-adrenergic blocking agent, or appropriate substitute, to control reflex tachycardia.

Men’s ROGAINE (Minoxidil Topical 2% Solution) and Men’s ROGAINE FOAM 5% (Minoxidil Foam 5% w/w) are indicated for: • the treatment of male androgenetic alopecia (male pattern hair loss) on the top of the scalp (vertex). Women’s ROGAINE FOAM 5% (Minoxidil Foam 5%w/w) is indicated for: • the treatment of female androgenetic alopecia (female pattern hair loss) on the top of the scalp.

The effectiveness of Men’s ROGAINE, Men’s ROGAINE FOAM 5% and Women’s ROGAINE FOAM 5% in the treatment of receding hairlines has not been demonstrated in clinical trials. Men’s ROGAINE: the effect is maintained only for as long as the product is used.

Cessation of treatment will result in loss of the newly re-grown hair within about 3 months and progressive hair loss will resume. Men’s ROGAINE FOAM 5%: the persistence of effect after cessation of treatment for 16 weeks in men has not been demonstrated in clinical trials.

Persistence of effect while using Women’s ROGAINE FOAM 5% has been demonstrated for 24 weeks in clinical trials. 1 Pediatrics Pediatrics (<18 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for pediatric use.